Clinical trial Recruiting at 1 site Interventional Ages 0 Days to 28 Days

Music in the NICU: TÜMATA and Mozart to help newborns sleep and feel comfy

Official title: The Effect of Two Different Types of Music Played in a Neonatal Intensive Care Unit on Newborns' Sleep and Comfort Levels: A Crossover Randomized Controlled Trial

Run by Karamanoğlu Mehmetbey University · NCT07837180 · Data updated 2026-11-12

This trial tests whether TÜMATA or Mozart music helps newborns in the NICU sleep longer and feel more comfortable compared with routine care.

More Neonatal Intensive Care Unit trials

Quick facts

Study typeInterventional
Ages0 Days to 28 Days
SexAll
Enrollment48 (estimated)
SponsorKaramanoğlu Mehmetbey University
Academic / other
Locations1 site (Karaman)
StatusRecruiting
StartedMarch 15, 2025
Main results expectedDecember 31, 2026
Study endsMarch 15, 2027
Registry record updatedSeptember 23, 2026
Trial IDNCT07837180 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Newborns aged 0-28 days, term (≥38 weeks), admitted to the NICU, breathing spontaneously, with parental consent.

Probably not a fit

Very preterm or unwell infants, those with recent analgesic/sedative use, respiratory problems, or whose parents decline participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this prospective, single-blind, crossover study, newborns in the NICU will experience three conditions—TÜMATA music, Mozart classical music, and routine care—across separate study periods. Sleep duration and comfort will be measured with validated tools at predefined times to compare the effects of the different music types versus standard care. Eligible infants are term, breathing on their own, within 0-28 days old, and admitted to the NICU for at least 24 hours. The study aims to determine if music interventions can improve sleep and comfort in this setting while ensuring safety and parental consent.

Why it matters

Potential benefit: If successful, music interventions could become a simple, non-pharmacological option to improve sleep and comfort for hospitalized newborns.

How similar studies have gone: Prior research suggests music can support relaxation in newborns, but direct comparisons of TÜMATA and Mozart in the NICU are novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The infant must be in the neonatal period (aged 0-28 days).
* The infant must have been admitted to the Neonatal Intensive Care Unit.
* The infant must have been born at term (38 weeks or more).
* The infant must be breathing spontaneously.
* The infant must have finished feeding at least 30 minutes prior to the procedure.
* The infant must not have received any analgesics and/or sedatives within the last 8 hours.
* The parents must have consented to participate in the study.
* The infant must have been admitted for at least 24 hours.

Exclusion Criteria:

* Newborns readmitted during the data collection period.
* Newborns with respiratory problems.
* Newborns whose parents declined to participate in the study.

Criteria for Withdrawal from the Study:

* A change in the newborn's vital signs.
* The parent's request to withdraw the newborn from the study.

Where it's running

  • Karaman Training and Research Hospital
    Karaman, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.